Welcome to IRPB Lisbon 2015!
We will be looking into the theme of 'Optimization of therapy' for the conference and creating a programme split into sections to reflect this theme. The traditional, clinically-orientated expert reviews which make up the core of the IRPB will continue, as will sessions discussing new and existing pharmacological therapies, but these will be augmented by parallel sessions involving a variety of new themes and initiatives for 2015.
The conference will review recent exciting progress in genetic screening in Psychiatry, with special reference to how it can be used in the clinic today. Perhaps more importantly, we anticipate a lively debate on the ethics of genetic screening and appropriate patient counselling. In addition the conference will be reviewing adherence strategies and techniques to ensure optimal adherence and minimal relapse rates for patients, creating practical scenarios and workshops to help clinicians achieve long term remission for their patients.
To this end we welcome presentations and exhibitions from genetic screening (and associated) companies, and companies developing or promoting adherence-encouragement technologies.
The following table represents an overview of the current programme (click here download the pdf version)
Ensuring good compliance remains a key objective for both schizophrenia and bipolar disorders and remains an elusive ideal for many patients. New therapies have, in recent times, been introduced to attempt to help patients maintain a sufficient level of active drug substance on receptors in the brain. IRPB will review these new therapies and their utility amongst the wider patient population.
IRPB will be working with a number of associated organizations and offering sections of the programme to these organizations to design plenaries, interactive sessions, debates and workshops around the central theme, but from the point of view of the associated organization. Associated organizations can include commercially-orientated organizations.
Finally, Mental Health always seems to be an area struggling to remain sufficiently resourced, especially in these hard economic times. The conference will review Policy initiatives and ask if more can be done at National and International levels to help resourcing of services.
We welcome all submissions and suggestions at this point for the programming committee to review.
The objective is to achieve a first draft programme by the end of October 2014.
As we stand at the dawn of a new diagnostic age for Psychiatry, we look forward to a lively and exciting IRPB 2015.
With best wishes,
Conference and Association Director